Mahamaya Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 265.75 | 161.62 | 137.19 |
| Operating Expenses Annual | 241.19 | 148.15 | 128.24 |
| Operating Profit Annual | 25.87 | 14.67 | 9.15 |
| Interest Annual | 6.83 | 5.74 | 2.62 |
| Depreciation | 1.77 | 1.41 | 0.83 |
| Net Profit Annual | 12.82 | 5.47 | 3.73 |
| Tax Annual | 4.44 | 2.05 | 1.48 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 265.75 |
| Operating Expenses Annual | 241.19 |
| Operating Profit Annual | 25.87 |
| Interest Annual | 6.83 |
| Depreciation | 1.77 |
| Net Profit Annual | 12.82 |
| Tax Annual | 4.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.09 | 1.40 | 0.77 |
| Cash Flow from Operations | -3.35 | -23.46 | 0.81 |
| Cash Flow from Investing | -4.43 | -1.38 | -2.78 |
| Cash Flow from Financing | 8.47 | 24.53 | 2.59 |
| Cash Flow at the End | 1.78 | 1.09 | 1.40 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.09 |
| Cash Flow from Operations | -3.35 |
| Cash Flow from Investing | -4.43 |
| Cash Flow from Financing | 8.47 |
| Cash Flow at the End | 1.78 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 9.73 | 9.08 | 6.75 |
| PBIT Margin (%) | 9.07 | 8.20 | 5.79 |
| PBT Margin (%) | 7.74 | 6.77 | 3.67 |
| Net PROFIT Margin (%) | 4.82 | 3.38 | 2.72 |
| Return On Networth / Equity (%) | 34.16 | 24.37 | 18.92 |
| Return On Networth /Employed (%) | 25.56 | 21.29 | 17.89 |
| Return On Assets (%) | 13.60 | 8.80 | 8.40 |
| Total Debt / Equity (X) | 1.50 | 1.76 | 1.24 |
| Asset Turnover Ratio (%) | 2.82 | 2.60 | 3.09 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 9.73 |
| PBIT Margin (%) | 9.07 |
| PBT Margin (%) | 7.74 |
| Net PROFIT Margin (%) | 4.82 |
| Return On Networth / Equity (%) | 34.16 |
| Return On Networth /Employed (%) | 25.56 |
| Return On Assets (%) | 13.60 |
| Total Debt / Equity (X) | 1.50 |
| Asset Turnover Ratio (%) | 2.82 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 31.17 | 24.45 | 23.52 |
| Total Current Assets Annual | 157.04 | 87.66 | 54.38 |
| Non Current Assets Annual | 31.67 | 24.83 | 23.89 |
| Total Shareholders Funds Annual | 49.87 | 25.18 | 19.71 |
| Total Assets Annual | 188.71 | 112.49 | 78.27 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 31.17 |
| Total Current Assets Annual | 157.04 |
| Non Current Assets Annual | 31.67 |
| Total Shareholders Funds Annual | 49.87 |
| Total Assets Annual | 188.71 |
EPS (INR)
Expected
0.00
Reported
0.00
Surprise
0.00%
